Longboard pharmaceuticals appoints life sciences executive dr. jane tiller to board of directors

San diego, nov. 17, 2021 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the appointment of jane tiller, mbchb, frcpsych, to its board of directors.

LBPH Ratings Summary

LBPH Quant Ranking